G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications.
about
Science review: Vasopressin and the cardiovascular system part 1--receptor physiologyPhosphorylation of GRK1 and GRK7 by cAMP-dependent protein kinase attenuates their enzymatic activitiesCalmodulin is a phospholipase C-beta interacting proteinAgonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacyDesign, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptorDown-regulation of the alpha-2C adrenergic receptor: involvement of a serine/threonine motif in the third cytoplasmic loopPharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDPhosphorylation of phosducin and phosducin-like protein by G protein-coupled receptor kinase 2Acidic amino acids flanking phosphorylation sites in the M2 muscarinic receptor regulate receptor phosphorylation, internalization, and interaction with arrestinsEarly to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonistsDuplexed label-free G protein--coupled receptor assays for high-throughput screening.The evidence on tiotropium bromide in asthma: from the rationale to the bedside.What molecular events underlie heterologous desensitization? Focus on "receptor phosphorylation does not mediate cross talk between muscarinic M(3) and bradykinin B(2) receptors".Rhodopsin and its kinase.Molecular and pharmacological properties of insect biogenic amine receptors: lessons from Drosophila melanogaster and Apis mellifera.Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor.Label-Free Receptor Assays.Downregulation of kinin B1 receptor function by B2 receptor heterodimerization and signaling.Identification and functional characterization of the phosphorylation sites of the neuropeptide FF2 receptor.Heterologous down-regulation of angiotensin type 1 receptors by purinergic P2Y2 receptor stimulation through S-nitrosylation of NF-kappaB.Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin-releasing hormone receptor: role of cellular calcium and protein kinase C.EP1- and FP-mediated cross-desensitization of the alpha (alpha) and beta (beta) isoforms of the human thromboxane A2 receptor.MFG-E8 inhibits neutrophil migration through αvβ₃-integrin-dependent MAP kinase activation.A serine cluster prevents recycling of the V2 vasopressin receptorGRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.Milk fat globule-epidermal growth factor-factor 8 attenuates neutrophil infiltration in acute lung injury via modulation of CXCR2.Dynamic distribution of chemoattractant receptors in living cells during chemotaxis and persistent stimulationInhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein kinases in mammalian cells in cultureDesensitization of herpesvirus-encoded G protein-coupled receptors.Aminergic control and modulation of honeybee behaviourRole of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease.RGS13 controls g protein-coupled receptor-evoked responses of human mast cells.Hypocretin/Orexin Peptides Alter Spike Encoding by Serotonergic Dorsal Raphe Neurons through Two Distinct Mechanisms That Increase the Late AfterhyperpolarizationPeptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.The KDEL receptor: new functions for an old protein.High-fat diet induces protein kinase A and G-protein receptor kinase phosphorylation of β2 -adrenergic receptor and impairs cardiac adrenergic reserve in animal hearts.Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium.Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.Signals and Receptors.
P2860
Q21195090-4E584716-7F54-4627-A0A5-A2AD9C1BA974Q24305031-5056EC34-A18E-4FD0-B615-510D4E30DCE2Q24306238-811283CB-2E20-44D8-9D21-E8C21A18C59FQ24321991-41A8E220-0DC4-48FC-A6A0-72EEB5D9D0E2Q24649952-4E1F9C0E-375C-4BBE-A10F-AA78626CBB1EQ24806621-9A549FFD-7EF7-4041-83AF-063C9C4064CAQ26778685-038036A6-73F2-4E05-B470-A7459A0502F0Q28140208-3F303AA7-50A6-48B9-ABF0-1A418B2905ADQ28144294-963C1EA2-6F60-446D-94C1-9100DA82D75FQ28361243-12B1CCDA-C028-41C9-9F45-C135195D1497Q33386660-0718A3A9-B2AF-4281-8C70-66820420C27AQ33644971-1E34FA69-37D6-414D-9D66-3D6863C30626Q33774767-975D54D0-87EE-4530-ACF0-5C0E8B0E6122Q34343081-3405F368-ADF5-4C75-B94C-0BC07BAACE25Q34344342-819FF1BC-8DAD-4944-88EA-302BB0A9F3A0Q34353797-DC177E51-4595-45ED-B079-DEDD7697F487Q34473007-C30D6359-4F07-4CD8-8ECE-509302864102Q34617439-76A76B9F-FBF5-4DBC-BEBA-B9725B10FD71Q34634103-F03D1041-F7BA-443E-902C-86F051526F4AQ34835284-DC819725-568C-4F0E-B182-EEDB475064B2Q35028565-8ADD89C5-89D0-427C-8186-D3F553A1516AQ35047084-6E6841C9-3827-4D63-BA56-E05505FFD679Q35827660-A00CCFD9-B540-4CA3-A73B-EDC5D20D7349Q35908261-89A363D1-046A-4DB9-8AC4-5D2B5A330BE1Q35921655-9A9F0B77-5ECD-4A28-A50F-4302FFD37D2EQ36055141-8D3C2D22-FF3C-4D59-A0D4-9D64D5B68FB6Q36273918-E91DE0FC-3E91-467E-800A-B7EC3677A8AFQ36400438-F278AB20-23A7-4364-860C-39FA357E6557Q36454708-B7216EC1-29A7-4F2A-ADD3-52C815309932Q36778310-5743B5D8-03B1-4564-AF09-78FC11107F1FQ37129351-60E583C5-3F0E-49F8-B2FC-D468C115C47CQ37219296-A43C4304-BECC-443C-A71C-37ED8A9A06A5Q37290211-73E5D94D-865D-4E9C-8ECD-A86EB320879FQ37378273-32028F44-D6CA-4448-960E-D06B0A5BA078Q37578475-2B4BE59D-4E4D-4BF3-ABED-23CD74B86361Q37620952-17F90915-7107-4CB3-95C1-3D98835B3B95Q37700020-0D49D622-A925-41C3-B231-99AB2E9FA205Q38362661-21108589-DE33-431F-96FF-4BAE6400F1D1Q38550921-ED2C207E-5023-457B-B2DF-F8AF7A6C5187Q38796060-63D65DC6-76BB-433C-B190-3D8C9949F362
P2860
G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
G protein-coupled receptors: h ...... tization and its implications.
@en
type
label
G protein-coupled receptors: h ...... tization and its implications.
@en
prefLabel
G protein-coupled receptors: h ...... tization and its implications.
@en
P2093
P1476
G protein-coupled receptors: h ...... itization and its implications
@en
P2093
A De Blasi
L Iacovelli
T T Chuang
P304
P356
10.1016/S0165-6147(96)10048-1
P577
1996-11-01T00:00:00Z